Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Cash (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Change in Cash for 6 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 61.6% year-over-year to $2.4 million, compared with a TTM value of -$4.0 million through Dec 2025, down 185.92%, and an annual FY2025 reading of -$4.0 million, down 185.92% over the prior year.
  • Change in Cash was $2.4 million for Q4 2025 at Viemed Healthcare, up from -$8.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $9.9 million in Q2 2025 and bottomed at -$13.3 million in Q2 2023.
  • Average Change in Cash over 5 years is -$874000.0, with a median of $85000.0 recorded in 2021.
  • The sharpest move saw Change in Cash tumbled 13666.67% in 2022, then surged 1839.73% in 2024.
  • Year by year, Change in Cash stood at $1.5 million in 2021, then plummeted by 396.17% to -$4.6 million in 2022, then soared by 160.5% to $2.8 million in 2023, then skyrocketed by 124.3% to $6.2 million in 2024, then tumbled by 61.6% to $2.4 million in 2025.
  • Business Quant data shows Change in Cash for VMD at $2.4 million in Q4 2025, -$8.9 million in Q3 2025, and $9.9 million in Q2 2025.